ICD-10-CM Billable Code

T46.3X5

Adverse effect of coronary vasodilators

Clinical Classification Guidelines

Medical Intelligence & Overview

The ICD-10 code T46.3X5 pertains to adverse effects resulting from the use of coronary vasodilators, which are medications used to widen the coronary arteries. These medications help improve blood flow to the heart muscle, especially in conditions like angina. However, like all drugs, they can sometimes cause unwanted side effects that need to be monitored and managed under medical supervision. Recognizing these adverse effects is important for ensuring safe treatment and timely intervention.

Causes & Symptoms

Clinical Causes: Overdose or incorrect dosage of coronary vasodilators Individual hypersensitivity or allergic reactions to the medication Drug interactions with other medications affecting blood vessels or heart function Underlying health conditions that alter drug metabolism or response Prolonged use or inappropriate use of vasodilators

Key Symptoms: Dizziness or lightheadedness, especially when standing up quickly Headache or flushing due to widened blood vessels Low blood pressure (hypotension) Rapid heartbeat (tachycardia) Nausea or gastrointestinal discomfort Swelling in the extremities or ankles Fainting episodes Chest discomfort or irregular heartbeat in some cases

Diagnostic & Treatment

Diagnosis Path: To identify adverse effects caused by coronary vasodilators, healthcare providers will review the patient's medical history, medication use, and symptom presentation. Diagnostic steps may include:

Treatment Protocols: Managing adverse effects from coronary vasodilators involves:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is T46.3X5 a billable ICD-10 code?
Yes, T46.3X5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report T46.3X5?
Clinical documentation must specify the nature of Adverse effect of coronary vasodilators and any associated comorbidities for accurate reporting.

Cite this Clinical Reference